Annual CFO
$14.03 M
+$12.88 M+1117.71%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual cash flow from operations is $14.03 million, with the most recent change of +$12.88 million (+1117.71%) on December 31, 2023.
- During the last 3 years, HBIO annual CFO has risen by +$4.70 million (+50.34%).
- HBIO annual CFO is now -15.03% below its all-time high of $16.51 million, reached on December 31, 2009.
Performance
HBIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$842.00 K
+$4000.00+0.47%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly cash flow from operations is -$842.00 thousand, with the most recent change of +$4000.00 (+0.47%) on September 30, 2024.
- Over the past year, HBIO quarterly CFO has dropped by -$5.20 million (-119.31%).
- HBIO quarterly CFO is now -110.75% below its all-time high of $7.83 million, reached on December 31, 2008.
Performance
HBIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$4.02 M
-$5.20 M-56.43%
September 30, 2024
Summary
- As of February 12, 2025, HBIO TTM cash flow from operations is $4.02 million, with the most recent change of -$5.20 million (-56.43%) on September 30, 2024.
- Over the past year, HBIO TTM CFO has dropped by -$8.39 million (-67.61%).
- HBIO TTM CFO is now -76.32% below its all-time high of $16.97 million, reached on September 30, 2009.
Performance
HBIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
HBIO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1117.7% | -119.3% | -67.6% |
| 3 y3 years | +50.3% | -27.6% | +10.5% |
| 5 y5 years | +386.4% | -126.7% | -50.1% |
HBIO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1117.7% | -119.3% | +57.6% | -71.4% | +247.8% |
| 5 y | 5-year | at high | +1117.7% | -119.3% | +57.6% | -71.4% | +247.8% |
| alltime | all time | -15.0% | >+9999.0% | -110.8% | +57.6% | -76.3% | +247.8% |
Harvard Bioscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$842.00 K(-0.5%) | $4.02 M(-56.4%) |
| Jun 2024 | - | -$846.00 K(-160.3%) | $9.22 M(-32.3%) |
| Mar 2024 | - | $1.40 M(-67.4%) | $13.62 M(-2.9%) |
| Dec 2023 | $14.03 M(+1117.7%) | $4.30 M(-1.3%) | $14.03 M(+13.1%) |
| Sep 2023 | - | $4.36 M(+22.8%) | $12.40 M(+42.7%) |
| Jun 2023 | - | $3.55 M(+96.0%) | $8.69 M(+75.6%) |
| Mar 2023 | - | $1.81 M(-32.4%) | $4.95 M(+329.7%) |
| Dec 2022 | $1.15 M(-8.7%) | $2.68 M(+312.8%) | $1.15 M(-181.7%) |
| Sep 2022 | - | $649.00 K(-441.6%) | -$1.41 M(-48.1%) |
| Jun 2022 | - | -$190.00 K(-90.4%) | -$2.72 M(+54.4%) |
| Mar 2022 | - | -$1.99 M(-1797.4%) | -$1.76 M(-239.5%) |
| Dec 2021 | $1.26 M(-86.5%) | $117.00 K(-117.7%) | $1.26 M(-65.3%) |
| Sep 2021 | - | -$660.00 K(-185.9%) | $3.63 M(-38.3%) |
| Jun 2021 | - | $768.00 K(-25.9%) | $5.89 M(-21.4%) |
| Mar 2021 | - | $1.04 M(-58.4%) | $7.50 M(-19.7%) |
| Dec 2020 | $9.33 M(+16.0%) | $2.49 M(+55.9%) | $9.33 M(+3.0%) |
| Sep 2020 | - | $1.60 M(-32.7%) | $9.06 M(-14.7%) |
| Jun 2020 | - | $2.37 M(-17.3%) | $10.62 M(+19.3%) |
| Mar 2020 | - | $2.87 M(+29.3%) | $8.91 M(+10.7%) |
| Dec 2019 | $8.04 M(+179.0%) | $2.22 M(-29.7%) | $8.04 M(-4.4%) |
| Sep 2019 | - | $3.16 M(+380.7%) | $8.42 M(+120.0%) |
| Jun 2019 | - | $657.00 K(-67.3%) | $3.83 M(-13.9%) |
| Mar 2019 | - | $2.01 M(-22.5%) | $4.45 M(+54.2%) |
| Dec 2018 | $2.88 M(+172.8%) | $2.59 M(-280.8%) | $2.88 M(-545.1%) |
| Sep 2018 | - | -$1.43 M(-212.3%) | -$648.00 K(-122.2%) |
| Jun 2018 | - | $1.28 M(+185.0%) | $2.92 M(+37.9%) |
| Mar 2018 | - | $448.00 K(-147.7%) | $2.12 M(+100.1%) |
| Dec 2017 | $1.06 M(-80.4%) | -$939.00 K(-144.1%) | $1.06 M(-71.6%) |
| Sep 2017 | - | $2.13 M(+348.6%) | $3.72 M(-26.0%) |
| Jun 2017 | - | $475.00 K(-177.9%) | $5.03 M(-8.5%) |
| Mar 2017 | - | -$610.00 K(-135.3%) | $5.50 M(+2.2%) |
| Dec 2016 | $5.38 M(+663.5%) | $1.73 M(-49.8%) | $5.38 M(-0.7%) |
| Sep 2016 | - | $3.44 M(+265.2%) | $5.42 M(+185.0%) |
| Jun 2016 | - | $942.00 K(-229.8%) | $1.90 M(+299.6%) |
| Mar 2016 | - | -$726.00 K(-141.2%) | $476.00 K(-32.5%) |
| Dec 2015 | $705.00 K(-83.8%) | $1.76 M(-2361.5%) | $705.00 K(+245.6%) |
| Sep 2015 | - | -$78.00 K(-83.9%) | $204.00 K(-76.9%) |
| Jun 2015 | - | -$484.00 K(-2.6%) | $884.00 K(-68.2%) |
| Mar 2015 | - | -$497.00 K(-139.4%) | $2.78 M(-36.1%) |
| Dec 2014 | $4.35 M(+7.2%) | $1.26 M(+109.8%) | $4.35 M(+0.3%) |
| Sep 2014 | - | $602.00 K(-57.4%) | $4.34 M(-16.0%) |
| Jun 2014 | - | $1.41 M(+31.9%) | $5.17 M(+13.4%) |
| Mar 2014 | - | $1.07 M(-14.2%) | $4.56 M(+12.2%) |
| Dec 2013 | $4.06 M(-49.6%) | $1.25 M(-12.7%) | $4.06 M(-3.7%) |
| Sep 2013 | - | $1.43 M(+78.0%) | $4.22 M(-20.3%) |
| Jun 2013 | - | $804.00 K(+39.6%) | $5.29 M(-24.8%) |
| Mar 2013 | - | $576.00 K(-59.0%) | $7.03 M(-12.8%) |
| Dec 2012 | $8.06 M | $1.41 M(-43.8%) | $8.06 M(-13.3%) |
| Sep 2012 | - | $2.50 M(-1.8%) | $9.30 M(+16.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $2.55 M(+58.8%) | $8.01 M(+12.6%) |
| Mar 2012 | - | $1.60 M(-39.3%) | $7.11 M(+6.9%) |
| Dec 2011 | $6.65 M(-45.9%) | $2.64 M(+118.4%) | $6.65 M(-19.5%) |
| Sep 2011 | - | $1.21 M(-26.7%) | $8.25 M(-7.2%) |
| Jun 2011 | - | $1.65 M(+44.3%) | $8.90 M(-13.9%) |
| Mar 2011 | - | $1.14 M(-73.1%) | $10.33 M(-16.0%) |
| Dec 2010 | $12.29 M(-25.5%) | $4.25 M(+129.4%) | $12.29 M(-20.3%) |
| Sep 2010 | - | $1.85 M(-39.9%) | $15.41 M(-3.5%) |
| Jun 2010 | - | $3.08 M(-0.8%) | $15.98 M(+4.3%) |
| Mar 2010 | - | $3.11 M(-57.8%) | $15.33 M(-7.2%) |
| Dec 2009 | $16.51 M(+79.4%) | $7.37 M(+205.0%) | $16.51 M(-2.7%) |
| Sep 2009 | - | $2.42 M(-0.5%) | $16.97 M(+23.4%) |
| Jun 2009 | - | $2.43 M(-43.4%) | $13.75 M(+7.6%) |
| Mar 2009 | - | $4.29 M(-45.2%) | $12.78 M(+38.9%) |
| Dec 2008 | $9.20 M(-23.7%) | $7.83 M(-1072.7%) | $9.20 M(+30.9%) |
| Sep 2008 | - | -$805.00 K(-154.9%) | $7.03 M(-33.7%) |
| Jun 2008 | - | $1.47 M(+105.8%) | $10.61 M(-2.8%) |
| Mar 2008 | - | $712.00 K(-87.4%) | $10.91 M(-9.5%) |
| Dec 2007 | $12.05 M(+44.3%) | $5.66 M(+103.8%) | $12.05 M(+51.3%) |
| Sep 2007 | - | $2.78 M(+57.0%) | $7.97 M(-1.8%) |
| Jun 2007 | - | $1.77 M(-4.6%) | $8.12 M(+3.6%) |
| Mar 2007 | - | $1.85 M(+17.9%) | $7.84 M(-6.2%) |
| Dec 2006 | $8.36 M(+60.8%) | $1.57 M(-46.3%) | $8.36 M(-22.8%) |
| Sep 2006 | - | $2.92 M(+96.7%) | $10.83 M(+49.3%) |
| Jun 2006 | - | $1.49 M(-37.3%) | $7.25 M(-1.9%) |
| Mar 2006 | - | $2.37 M(-41.4%) | $7.40 M(+42.4%) |
| Dec 2005 | $5.20 M(-54.6%) | $4.04 M(-722.3%) | $5.20 M(+1.1%) |
| Sep 2005 | - | -$650.00 K(-139.9%) | $5.14 M(-37.6%) |
| Jun 2005 | - | $1.63 M(+858.8%) | $8.23 M(-18.5%) |
| Mar 2005 | - | $170.00 K(-95.7%) | $10.11 M(-11.6%) |
| Dec 2004 | $11.44 M(+464.0%) | $3.99 M(+62.9%) | $11.44 M(+37.2%) |
| Sep 2004 | - | $2.45 M(-30.2%) | $8.34 M(+40.1%) |
| Jun 2004 | - | $3.50 M(+133.4%) | $5.95 M(+108.7%) |
| Mar 2004 | - | $1.50 M(+70.0%) | $2.85 M(+40.6%) |
| Dec 2003 | $2.03 M(+153.5%) | $883.00 K(+1301.6%) | $2.03 M(+1167.5%) |
| Sep 2003 | - | $63.00 K(-84.4%) | $160.00 K(-83.4%) |
| Jun 2003 | - | $405.00 K(-40.2%) | $962.00 K(-14.9%) |
| Mar 2003 | - | $677.00 K(-168.7%) | $1.13 M(+41.4%) |
| Dec 2002 | $800.00 K(-80.5%) | -$985.00 K(-213.9%) | $800.00 K(-76.8%) |
| Sep 2002 | - | $865.00 K(+50.7%) | $3.45 M(+47.0%) |
| Jun 2002 | - | $574.00 K(+65.9%) | $2.35 M(-18.3%) |
| Mar 2002 | - | $346.00 K(-79.2%) | $2.87 M(-29.9%) |
| Dec 2001 | $4.09 M(+90.8%) | $1.66 M(-802.1%) | $4.09 M(+68.4%) |
| Sep 2001 | - | -$237.00 K(-121.6%) | $2.43 M(-8.9%) |
| Jun 2001 | - | $1.10 M(-30.0%) | $2.67 M(+70.0%) |
| Mar 2001 | - | $1.57 M | $1.57 M |
| Dec 2000 | $2.15 M(-26.7%) | - | - |
| Dec 1999 | $2.93 M(>+9900.0%) | - | - |
| Dec 1998 | $27.00 K | - | - |
FAQ
- What is Harvard Bioscience annual cash flow from operations?
- What is the all time high annual CFO for Harvard Bioscience?
- What is Harvard Bioscience annual CFO year-on-year change?
- What is Harvard Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for Harvard Bioscience?
- What is Harvard Bioscience quarterly CFO year-on-year change?
- What is Harvard Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for Harvard Bioscience?
- What is Harvard Bioscience TTM CFO year-on-year change?
What is Harvard Bioscience annual cash flow from operations?
The current annual CFO of HBIO is $14.03 M
What is the all time high annual CFO for Harvard Bioscience?
Harvard Bioscience all-time high annual cash flow from operations is $16.51 M
What is Harvard Bioscience annual CFO year-on-year change?
Over the past year, HBIO annual cash flow from operations has changed by +$12.88 M (+1117.71%)
What is Harvard Bioscience quarterly cash flow from operations?
The current quarterly CFO of HBIO is -$842.00 K
What is the all time high quarterly CFO for Harvard Bioscience?
Harvard Bioscience all-time high quarterly cash flow from operations is $7.83 M
What is Harvard Bioscience quarterly CFO year-on-year change?
Over the past year, HBIO quarterly cash flow from operations has changed by -$5.20 M (-119.31%)
What is Harvard Bioscience TTM cash flow from operations?
The current TTM CFO of HBIO is $4.02 M
What is the all time high TTM CFO for Harvard Bioscience?
Harvard Bioscience all-time high TTM cash flow from operations is $16.97 M
What is Harvard Bioscience TTM CFO year-on-year change?
Over the past year, HBIO TTM cash flow from operations has changed by -$8.39 M (-67.61%)